These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10459713)

  • 1. Treatment of periodic leg movement disorder and restless leg syndrome with talipexole.
    Inoue Y; Mitani H; Nanba K; Kawahara R
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):283-5. PubMed ID: 10459713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective sleep quality and suggested immobilization test in restless leg syndrome and periodic limb movement disorder.
    Inoue Y; Nanba K; Honda Y; Takahashi Y; Arai H
    Psychiatry Clin Neurosci; 2002 Jun; 56(3):293-4. PubMed ID: 12047601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
    Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
    Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
    Garcia-Borreguero D; Winkelman J; Adams A; Ellis A; Morris M; Lamb J; Layton G; Versavel M;
    Sleep Med; 2007 Mar; 8(2):119-27. PubMed ID: 17239657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic limb movement disorder and restless legs syndrome in dialysis patients.
    Rijsman RM; de Weerd AW; Stam CJ; Kerkhof GA; Rosman JB
    Nephrology (Carlton); 2004 Dec; 9(6):353-61. PubMed ID: 15663636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
    Wetter TC; Trenkwalder C; Stiasny K; Pollmächer T; Kazenwadel J; Kohnen R; Künzel M; Oertel WH
    Wien Med Wochenschr; 1995; 145(17-18):525-7. PubMed ID: 8588396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
    Stiasny K; Röbbecke J; Schüler P; Oertel WH
    Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
    Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-DOPA/carbidopa for nocturnal movement disorders in uremia.
    Walker SL; Fine A; Kryger MH
    Sleep; 1996 Apr; 19(3):214-8. PubMed ID: 8723378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs.
    Picchietti DL; Rajendran RR; Wilson MP; Picchietti MA
    Sleep Med; 2009 Sep; 10(8):925-31. PubMed ID: 19332386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.